Training in Neurotherapeutics for Academic Scientists

学术科学家神经治疗学培训

基本信息

  • 批准号:
    10539175
  • 负责人:
  • 金额:
    $ 27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2027-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract This project will develop and implement a training program in neurotherapeutics discovery and development for faculty members and advanced postdoctoral fellows, centered around a 4-day short course that will provide the trainees with the various knowledge elements required to discover and advance a neurotherapeutic agent – either small molecule or biological – to IND. The course is offered in conjunction with the American Society for Experimental Neurotherapeutics (ASENT). The training, which is designed to be applicable to diverse diseases of the nervous system, will equip students with a broad understanding of the various component steps in the neurotherapeutics drug discovery and development process. Students will learn how to identify a good drug discovery target; how to construct an assay; the elements of medicinal chemistry; how to conduct animal efficacy testing; the principles of ADME studies, safety testing, and formulation; special considerations for development of biological products, including monoclonal antibodies, oligonucleotides and viral vector gene therapies; the steps required to prepare an IND document and the principles for interacting with the FDA; the principles of intellectual property as they relate to neurotherapeutics discovery and development; and how to seek funding for academic drug discovery research. They will also receive training in responsible conduct of research. Students will be equipped with the skills to develop and coordinate an entire drug discovery and development effort, and to work collaboratively with experts in each of the component areas. The training will combine didactic lectures with active engagement activities in which the students will be challenged to utilize the lecture material to work through their own drug discovery project plan with the guidance of the area experts. The 4-day short course will be offered annually, a total of five times. After attending the short course, trainees will participate in ongoing activities that provide continuing professional development through engagement with ASENT.
项目摘要/摘要 该项目将开发和实施一个神经疗法发现和培训计划 针对教员和高级博士后研究员的发展,以为期4天的短期课程为中心 这将为学员提供所需的各种知识元素,以发现和提高 神经治疗剂--无论是小分子还是生物--用于IND。该课程与 美国实验神经治疗学会(ASENT)。这项培训旨在 适用于各种神经系统疾病,将使学生对神经系统疾病有广泛的了解 神经治疗药物发现和开发过程中的各个组成部分。学生们将 学习如何确定一个好的药物发现目标;如何构建一种分析方法;药物的要素 化学;如何进行动物药效试验;ADME研究、安全试验和 配方;开发生物制品,包括单抗的特别考虑, 寡核苷酸和病毒载体基因疗法;准备IND文件和 与FDA互动的原则;与之相关的知识产权原则 神经治疗学的发现和发展;以及如何为学术药物发现寻求资金 研究。他们还将接受负责任地进行研究的培训。学生们将被配备 开发和协调整个药物发现和开发工作的技能,以及 与每个组成部分领域的专家协作。培训将结合说教讲座和 主动参与的活动,学生将被要求利用讲课材料进行工作 通过自己的药物发现项目计划,在地区专家的指导下完成。为期4天的短期课程 将每年举办一次,共五次。参加完短期课程后,学员将参加 持续的活动,提供持续的专业发展,通过与美国职业教育协会的接触。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL A. ROGAWSKI其他文献

MICHAEL A. ROGAWSKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL A. ROGAWSKI', 18)}}的其他基金

Training in Neurotherapeutics for Academic Scientists
学术科学家神经治疗学培训
  • 批准号:
    10666685
  • 财政年份:
    2022
  • 资助金额:
    $ 27万
  • 项目类别:
TRAINING IN NEUROTHERAPUETICS AND DEVELOPMENT FOR ACADEMIC SCIENTISTS
学术科学家的神经治疗学和发展培训
  • 批准号:
    9910467
  • 财政年份:
    2017
  • 资助金额:
    $ 27万
  • 项目类别:
Identification of Treatments for Chemical Threat Agent Seizures
查获化学威胁剂的治疗方法的确定
  • 批准号:
    10204124
  • 财政年份:
    2012
  • 资助金额:
    $ 27万
  • 项目类别:
EVALUATION OF NOVEL EPILEPSY TREATMENT APPROACHES
新型癫痫治疗方法的评估
  • 批准号:
    6111907
  • 财政年份:
  • 资助金额:
    $ 27万
  • 项目类别:
Evaluation Of Novel Epilepsy Treatment Approaches
新型癫痫治疗方法的评价
  • 批准号:
    7143877
  • 财政年份:
  • 资助金额:
    $ 27万
  • 项目类别:
Evaluation Of Novel Epilepsy Treatment Approaches
新型癫痫治疗方法的评价
  • 批准号:
    6842958
  • 财政年份:
  • 资助金额:
    $ 27万
  • 项目类别:
Epilepsy: Ion Channels As Antiepileptic Targets
癫痫:离子通道作为抗癫痫靶点
  • 批准号:
    6990039
  • 财政年份:
  • 资助金额:
    $ 27万
  • 项目类别:
Identification of treatments for chemical threat agent seizures
确定化学威胁剂缉获的治疗方法
  • 批准号:
    8851849
  • 财政年份:
  • 资助金额:
    $ 27万
  • 项目类别:
Ion Channels in Epilepsy and as Targets for Antiepilepti
癫痫中的离子通道和抗癫痫靶标
  • 批准号:
    7143853
  • 财政年份:
  • 资助金额:
    $ 27万
  • 项目类别:
ION CHANNELS IN EPILEPSY AND AS TARGETS FOR ANTIEPILEPTIC DRUGS
癫痫中的离子通道及其作为抗癫痫药物的靶标
  • 批准号:
    6290637
  • 财政年份:
  • 资助金额:
    $ 27万
  • 项目类别:

相似海外基金

Conference: Rethinking how language background is described in academia and beyond
会议:重新思考学术界及其他领域如何描述语言背景
  • 批准号:
    2335912
  • 财政年份:
    2024
  • 资助金额:
    $ 27万
  • 项目类别:
    Standard Grant
ADVANCE Catalyst: Virtual Observatory of Culture for Equity in Academia at the University of Puerto Rico Rio Piedras (VoCEA)
ADVANCE Catalyst:波多黎各 Rio Piedras 大学学术界平等文化虚拟观察站 (VoCEA)
  • 批准号:
    2214418
  • 财政年份:
    2023
  • 资助金额:
    $ 27万
  • 项目类别:
    Standard Grant
Comprehensive development strategy of modality-specific "intellectual property" and "cultivation" with an eye on "pharmaceutical affairs" in academia drug discovery
学术界新药研发着眼“药事”的模式“知识产权”与“培育”综合发展策略
  • 批准号:
    23K02551
  • 财政年份:
    2023
  • 资助金额:
    $ 27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating Research Advancement for Investigators Underrepresented in Academia
加速学术界代表性不足的研究人员的研究进展
  • 批准号:
    10746315
  • 财政年份:
    2023
  • 资助金额:
    $ 27万
  • 项目类别:
Planning: HBCU-UP: Strengthening Data Science Research Capacity and Education Programs through Academia-Industry Partnership
规划:HBCU-UP:通过学术界与工业界合作加强数据科学研究能力和教育计划
  • 批准号:
    2332161
  • 财政年份:
    2023
  • 资助金额:
    $ 27万
  • 项目类别:
    Standard Grant
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
从学术界到商界:针对 HPV 相关癌症的新型疗法的开发
  • 批准号:
    10813323
  • 财政年份:
    2023
  • 资助金额:
    $ 27万
  • 项目类别:
Academics4Rail: Building a community of railway scientific researchers and academia for ERJU and enabling a network of PhDs (academia teaming with industry)
Academys4Rail:为ERJU建立铁路科研人员和学术界社区并建立博士网络(学术界与工业界合作)
  • 批准号:
    10087488
  • 财政年份:
    2023
  • 资助金额:
    $ 27万
  • 项目类别:
    EU-Funded
Academics4Rail: Building a Community of Railway Scientific Researchers and Academia for ERJU and Enabling a Network of PhDs (Academia Teaming with Industry)
Academys4Rail:为二院建立铁路科研人员和学术界社区并启用博士网络(学术界与工业界合作)
  • 批准号:
    10102850
  • 财政年份:
    2023
  • 资助金额:
    $ 27万
  • 项目类别:
    EU-Funded
Exploring the overall picture of industry-academia-government collaboration: A spectrum of knowledge transfer through formal and informal channels
探索产学官合作的整体图景:通过正式和非正式渠道进行的一系列知识转移
  • 批准号:
    22K01692
  • 财政年份:
    2022
  • 资助金额:
    $ 27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project
促进道德神经技术学术界与工业界的伙伴关系:利益相关者参与和工具包开发项目
  • 批准号:
    10655632
  • 财政年份:
    2022
  • 资助金额:
    $ 27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了